Following the publication of the joint letter to pharmacy owners about changes to the Community Pharmacy Contractual Framework (CPCF) in 2025/26, published on 31st March 2025, we have been working with NHS England and DHSC to finalise all the necessary requirements for the agreed changes to the contract to be introduced. This has included NHS
Read moreProfessor Dame Jenny Harries DBE DL, former Deputy Chief Medical Officer for England, has been appointed as non-executive Chair of the Community Pharmacy England Committee. Professor Harries brings a wealth of expertise from working in public health across all levels of Government. Through previous roles as Deputy Chief Medical Officer for England, and the founding
Read moreThe Department of Health and Social Care (DHSC) has today (29/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Nefopam 30mg tablets 90 £4.09 Olanzapine 10mg tablets 28 £4.99 Olanzapine 2.5mg tablets 28 £3.51 Olanzapine 20mg tablets 28 £4.99 Olanzapine 7.5mg tablets 28 £1.25 Propranolol 80mg modified-release capsules 28 £5.94 Repaglinide
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 September 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Simeticone 42mg/5ml oral drops Dentinox® Infant colic drops (Dendron Brands Ltd) 100 ml
Read moreFrom 1 September 2025, Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the September 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to reflect the
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 September 2025. This takes the total number
Read moreWhen the revised service specification for the 2025/26 Adult Flu Vaccination service was published last month, we informed pharmacy owners that the fee for this year was still under consideration by Ministers, following our submission of an evidence-based case for an increase in the fee. The decision has now been set out in the Drug
Read moreThe Department of Health and Social Care (DHSC) has today (28/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £51.02 Amiodarone 100mg tablets 28 £2.24 Amiodarone 200mg tablets 28 £4.82 Buprenorphine 2mg sublingual tablets sugar free 7 £1.83 Carbocisteine 250mg/5ml oral solution 300 £4.99 Co-amoxiclav
Read moreThe Department of Health and Social Care (DHSC) has today (27/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £31.95 Bumetanide 1mg tablets 28 £2.94 Buprenorphine 8mg sublingual tablets sugar free 7 £6.00 Co-codamol 30mg/500mg effervescent tablets 32 £2.40 Co-codamol 30mg/500mg effervescent
Read more“While implementation of the 2025/26 CPCF continues at pace, our sights are also set on the future,” writes Community Pharmacy England Chief Executive Janet Morrison in a new blog. Despite the funding uplift earlier this year, pharmacy businesses remain in a financially precarious position. Janet explains that the views of pharmacy owners and their experiences
Read more
